The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 100

More JCP Articles

JCP
Clinical and Practical Psychopharmacology

October 2, 2018

Pregabalin is used for many indications across the world, including pain syndromes and generalized anxiety disorder. If a woman receiving pregabalin discovers she is pregnant or wishes to become…
JCP
Original Research

October 2, 2018

Tobacco has known associations with psychosis, but less is known about the relationship between tobacco use and subclinical psychotic-like experiences (PLEs). This study sought to disentangle the association of…
, , , et al
JCP
Original Research

October 2, 2018

People who have received inpatient psychiatric care are at greater risk of dying an unnatural death. This study, which drew on data from persons born in Denmark from 1967-1996,…
, , , et al
JCP
Original Research

September 25, 2018

Once a patient is discharged after a suicide attempt, what can be done to prevent another attempt? This study evaluated a suicide prevention strategy algorithm versus treatment as usual…
, , , et al
JCP
Original Research

September 25, 2018

Treatment nonadherence is bipolar disorder ranges from 20% to 60%. Read this article to learn how customized adherence enhancement (CAE)—a brief, bipolar disorder-specific approach that targets individual adherence barriers—compared…
, , , et al
JCP
Original Research

September 25, 2018

Polypharmacy has been shown to be associated with dementia, though its relationship to mild cognitive impairment (MCI), often a precursor to dementia, has received less study. Read this article…
, , , et al
JCP
Clinical and Practical Psychopharmacology

September 25, 2018

Two recent meta-analyses examined an intriguing possibility: the usefulness of statins as antipsychotic augmentation. In this installment of Clinical and Practical Psychopharmacology, Dr Andrade takes a critical look at…
JCP
Clinical and Practical Psychopharmacology

September 25, 2018

Two recent meta-analyses examined an intriguing possibility: the usefulness of statins as antipsychotic augmentation. In this installment of Clinical and Practical Psychopharmacology, Dr Andrade takes a critical look at…
JCP
Article

September 18, 2018

When choosing among agents for treating PTSD, which one should you pick? Fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine have all shown efficacy. This large retrospective VA study compared the…
, , , et al
JCP
Meta-Analysis

September 18, 2018

Tardive dyskinesia, a side effect of antipsychotics, is a persistent and disabling problem among patients with schizophrenia. Could a switch to clozapine help? This meta-analysis looks at 16 studies…
, , , et al
JCP
Original Research

September 18, 2018

Cardiovascular diseases are the primary cause of mortality in individuals with schizophrenia, yet no study has yet explored the impact of metabolic syndrome on schizophrenia relapse. This study explored…
, , , et al
JCP
Original Research

September 11, 2018

Children who have experienced victimization such as maltreatment or violence are at risk for problems that include, but extend beyond, PTSD. To guide assessment and treatment of these youth,…
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe